On Saturday the 25th of June, Neuro-Bio’s CEO Susan Greenfield, will speak at the opening session of the EAN 2022 congress, the biggest meeting in Neurology! Her talk will be “Where Neuroscience meets neurology: blowing, expanding, and losing the...
During her trip to Australia, Neuro-Bio’s CEO, Susan Greenfield had an interview with Julie Hare, Education editor for the Australian “Financial Review”. In April, Baroness Professor Greenfield published a research paper that proved a drug developed...
On Monday the 30th of May, Neuro-Bio’s operations director, Sara Garcia-Rates, will be presenting at virtual AIMday in Translational Dementia Research, hosted by the University of Oxford. Sara will be talking about Neuro-Bio’s research in a workshop from 10.15...
On Sunday the 22nd of May, Neuro-Bio was mentioned in an article on the DailyMail. To read the full article click the link.
Neuro-Bio welcomes Anna Ashton as senior postdoc scientist. Anna has over ten years’ experience in research spanning pharmaceutical, biotech and academic labs. She graduated with a PhD in Medical Sciences from the University of Aberdeen, in which she studied the role...
On Wednesday the 25th of May, Neuro-Bio’s, Susan Greenfield, will travel to Australia to meet the company’s shareholders and investors and will be there until the 4th of June. The office and lab will be open as...
